American Century Companies’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
VCM
JHC
American Century Companies's TNXP Position: Q1 2026 in Review
American Century Companies held its Tonix Pharmaceuticals (TNXP) position steady in Q1 2026 at 12,850 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2730.
American Century Companies first reported a position in TNXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $243K in Q3 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.
- American Century Companies held 12,850 shares of Tonix Pharmaceuticals worth $177K as of Q1 2026.
- American Century Companies left its Tonix Pharmaceuticals share count unchanged in Q1 2026.
- Tonix Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2730 holding.
- American Century Companies first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- American Century Companies's Tonix Pharmaceuticals position peaked at $243K in Q3 2025.
- 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.